EUVIMEDEUVIMED entdecken
Crossref

Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication

Giovanni Maconi, Federica Lepore, Adam Saleh, Simone Saibeni, Cristina Bezzio, Stefania Cheli, Alessandro Massari, Daniele Gridavilla, Francesca Ferretti, Rosanna Cannatelli, Sandro Ardizzone, Emilio Clementi und 1 weitere

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2024.05.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Giovanni Maconi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, ASST Fatebenefratelli-Sacco, Department of Biomedical and Clinical Sciences L. Sacco University Hospital, University of Milan,…. Hauptthemen laut MEDLINE: Crohn Disease, Adalimumab, Infliximab, Remission Induction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Transmural healing is a long-term target for patients with Crohn's disease. Factors contributing to its promotion are poorly understood. This study assessed factors correlating with transmural healing based on intestinal ultrasound, in patients in long-term clinical remission on anti-TNF. METHODS: 68 consecutive Crohn's patients on adalimumab (50) or infliximab (18) therapy with clinical remission ≥1 year were recruited and assessed for clinical features, trough serum levels of anti-TNF and intestinal ultrasound findings. Univariate analysis and multivariate binary logistic regression analysis identified variables independently associated with bowel wall thickening behavior. RESULTS: Sixty eight patients were in remission for a mean of 4.1 years. Thirty-six patients (52.9 %) showed anti-TNF trough levels below the normal threshold. Twenty-two patients (38.4 %) showed transmural healing, 32 (47.1 %) transmural response, and 26 (38.2 %) no treatment response. Transmural healing correlated with higher BMI and lower baseline bowel wall thickening; transmural response correlated with short Crohn's disease duration, high drug levels, and with non-stricturing phenotype. Treatment non-response correlated with lower BMI, lower drug levels, higher baseline bowel wall thickening, and stricturing phenotype. CONCLUSIONS: Lack of transmural healing in stable remission Crohn's patients on anti-TNF therapy is multifactorial, mainly due to low anti-TNFs trough levels, development of strictures, and higher baseline bowel wall thickening at treatment initiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseAdalimumabInfliximabRemission InductionTumor Necrosis Factor-alphaHumansMaleFemaleAdultMiddle AgedUltrasonographyLogistic ModelsWound HealingMultivariate AnalysisYoung AdultTreatment Outcome

Stichwörter der Autor:innen

AdalimumabCrohn's diseaseInfliximabTransmural healingTumor necrosis factor inhibitorsUltrasound

Substanzen

AdalimumabInfliximabTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Gastroenterology Unit, ASST Fatebenefratelli-Sacco, Department of Biomedical and Clinical Sciences L. Sacco University Hospital, University of Milan, Milan, Italy. Electronic address: giovannni.maconi@unimi.it.
  • Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Engineering Medicine, Texas A&M University, Houston, TX, USA.
  • Gastroenterology Unit, ASST Rhodense, Rho (MI) Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, University of Milan, Milan, Italy.

Zitieren

APA

Maconi, G., Lepore, F., Saleh, A., Saibeni, S., Bezzio, C., Cheli, S., Massari, A., Gridavilla, D., Ferretti, F., Cannatelli, R., Ardizzone, S., Clementi, E., & Abraham, B. (2024). Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.05.026

Vancouver

Maconi G, Lepore F, Saleh A, Saibeni S, Bezzio C, Cheli S, et al. Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.05.026

BibTeX
@article{Maconi2024,
  author = {Maconi, Giovanni and Lepore, Federica and Saleh, Adam and Saibeni, Simone and Bezzio, Cristina and Cheli, Stefania and Massari, Alessandro and Gridavilla, Daniele and Ferretti, Francesca and Cannatelli, Rosanna and Ardizzone, Sandro and Clementi, Emilio and Abraham, Bincy},
  title = {Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2024.05.026}
}
Kostenlos starten →